Showing results (281-290 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|January 27, 2017
Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected PatientsJosé Antonio Mata-Marín, Ariane Estrella Weiser Smeke, Mariana Rotzinger Rodriguez, et al.Drugs in R&D|January 8, 2017
Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports ProjectBeatrice J Edwards, Dennis W Raisch, Smita S Saraykar, et al.Drugs in R&D|January 21, 2017
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and ManagementNuno Vicente, Luís Cardoso, Luísa Barros, et al.Drugs in R&D|October 4, 2016
Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and DevelopmentBishwa B Adhikari, James L Goodson, Susan Y Chu, et al.Drugs in R&D|September 30, 2016
A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy SubjectsKo-Onn Lee, Chin-Meng Khoo, Balram Chowbay, et al.Drugs in R&D|January 17, 2004
Huperzine ADrugs in R&D|January 17, 2004
Insulin inhalation: NN 1998Drugs in R&D|January 17, 2004
Motexafin gadolinium: gadolinium (III) texaphyrin, gadolinium texaphyrin, Gd-Tex, GdT2B2, PCI 0120Drugs in R&D|September 4, 2003
ABI 007Drugs in R&D|September 4, 2003
Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBDPageof 89